The system is intended for use in urgent care clinics, primary care settings, physician office laboratories, and pharmacies.
LEX Diagnostics receives US FDA 510(k) clearance and CLIA waiver for LEX VELO system: Cambridgeshire, UK Tuesday, February 17, 2026, 17:00 Hrs [IST] LEX Diagnostics, a leading inn ...
NEW YORK – Lex Diagnostics said on Monday that it has obtained 510 (k) clearance and CLIA waiver from the US Food and Drug Administration for its Velo point-of-care molecular diagnostic system and an ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する